Diana Aguilar Morante-rekin lankidetzan egindako argitalpenak (8)

2017

  1. CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson's disease

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: Role of C/EBPβ

    Journal of Neuroinflammation, Vol. 13, Núm. 1

2015

  1. CCAAT/Enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4

    Oncotarget, Vol. 6, Núm. 6, pp. 4369-4384

  2. CCAAT/enhancer binding protein β directly regulates the expression of the complement component 3 gene in neural cells: Implications for the pro-inflammatory effects of this transcription factor

    Journal of Neuroinflammation, Vol. 12, Núm. 1

  3. Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice

    Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1160-1173

2012

  1. The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury

    Journal of Neurochemistry, Vol. 122, Núm. 6, pp. 1193-1202

2010

  1. Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8

    PLoS ONE, Vol. 5, Núm. 11

2008

  1. Cancer stem cells and brain tumors

    Clinical and Translational Oncology, Vol. 10, Núm. 5, pp. 262-267